Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study
Nienke Folkeringa, Fleurisca J. Korteweg, Nic J.G.M. Veeger, Saskia Middeldorp, Karly Hamulyak, Martin H. Prins, Jan Jaap H.M. Erwich, Harry R. Büller, Jan van der MeerVolume:
123
Year:
2009
Language:
english
DOI:
10.1016/j.thromres.2008.02.014
File:
PDF, 186 KB
english, 2009